IL33 and metabolic syndrome: Here, the levels of IL-33 in patients with T2D with either controlled or uncontrolled metabolic syndrome were compared with normoglycemic controls, and it was observed that IL-33 was significantly decreased in both T2D groups, whereas ST2 was significantly increased.